查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018054

外骨骼市場：依產品類型、材料類型和應用分類－2026-2032年全球市場預測

Exoskeleton Market by Product Type, Material Type, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外骨骼市場價值將達到 11.9 億美元，到 2026 年將成長到 14.2 億美元，到 2032 年將達到 42.6 億美元，複合年成長率為 19.98%。

主要市場統計數據
基準年 2025 11.9億美元
預計年份：2026年 14.2億美元
預測年份 2032 42.6億美元
複合年成長率 (%) 19.98%

為高階主管提供簡潔而具有策略意義的指南，以協調技術、臨床檢驗和供應鏈選擇，從而推動實用外骨骼的實施。

隨著穿戴式機器人技術的興起，外骨骼正從小眾研究原型轉變為醫療、工業人體工學和無障礙領域中日益實用的工具。本執行摘要整合並說明了正在重塑外骨骼應用軌蹟的技術進步、監管趨勢、供應鏈發展以及相關人員的獎勵。摘要重點闡述了臨床檢驗、以使用者為中心的設計和生產規模如何相互交匯以創造競爭優勢，並提出了高階主管在投資產品開發、臨床試驗或策略夥伴關係時應考慮的營運權衡。

分析 2025 年美國關稅措施的變化將如何重塑外骨骼相關利害關係人的採購、製造地和採購風險管理。

2025年的貿易政策和關稅調整為整個外骨骼生態系統帶來了新的挑戰，包括籌資策略、供應商選擇和資本投資決策。部分進口零件關稅的提高，加上持續的物流不穩定和不斷變化的原產地要求，凸顯了製定更具韌性的籌資策略以及與供應商建立更緊密夥伴關係的重要性。這些變化迫使製造商調整材料清單（BOM），與主要供應商談判長期契約，並考慮本地或區域組裝，以降低關稅和運輸風險。

詳細的細分洞察展示了產品架構、材料選擇和應用重點如何為外骨骼設備創造獨特的商業性和技術路徑。

細分市場趨勢揭示了每種產品類型、材料選擇和應用領域不同的機會和風險概況。根據產品類型，市場被細分為全身外骨骼、下肢外骨骼和上肢外骨骼，並進行深入研究。下肢外骨骼進一步細分為非動力下肢外骨骼和動力下肢外骨骼，並進行詳細分析。上肢外骨骼進一步細分為胸部支撐、醫療輔助設備和肩部支撐，並進行詳細分析。全身系統擴大針對需要跨多個關節協調控制的複雜復健和工業任務，而下肢外骨骼則傾向於專注於職場的移動輔助和工作負荷重新分配。在下肢產品中，非動力解決方案強調被動支撐和經濟性，而動力下肢系統則優先考慮主動支撐和臨床級性能。上肢設備涵蓋了從被動胸部支撐到針對特定功能障礙和工作負荷分配的醫療肩部和胸部增強模組。

區域比較觀點揭示法律規範、採購慣例和製造生態系統如何影響全球市場對骨骼外骨骼的採用。

區域趨勢正在塑造創新、商業化和應用的發展方向，每個地區都展現出其獨特的法規環境、醫療保健重點和工業應用案例。在美洲，強勁的私營部門投資、渴望試點部署的醫療服務提供者網路，以及優先考慮穩健且可擴展服務模式的國防和工業應用案例，共同推動了這一趨勢。北美地區的監管環境日益注重示範性成果和互通性，要求供應商證明其長期效益並整合遠端監控功能，以贏得支付方和雇主的信任。

在主要外骨骼相關人員中，各公司呈現出一種策略趨勢，即強調平台化、基於證據的產品定位以及以服務為導向的收入模式。

競爭優勢日益取決於企業能否將卓越的硬體、經臨床驗證的成果和可擴展的服務組合起來。領先的開發商和製造商正在採用混合商業經營模式，將設備銷售與基於結果的服務、維護計劃和數據驅動的訂閱相結合。技術專家、臨床網路和工業經銷商之間的策略合作夥伴關係十分普遍，這有助於加速試驗計畫，並更深入地融入使用者工作流程。控制演算法、感測器融合和輕量化結構的智慧財產權組合是關鍵的差異化資產，可用於授權和交叉授權合約。

這份高階主管的可操作策略指導，透過關注易用性、證據產生、彈性供應鏈和基於結果的商業模式，加速了採用過程。

產業領導者應優先建構產品開發、臨床檢驗和供應鏈韌性等方面的整合能力，以抓住短期市場機會。投資於人因工程和迭代可用性測試，可降低產品被放棄的風險，並加速臨床醫生和第一線人員的接受度。同時，各機構應投資於長期臨床研究和真實世界數據 (REW) 的生成，以支持醫療系統和大型企業的採購決策，為更永續的商業化鋪平道路。

研究結果得到了透明且可重複的調查方法的支持，該方法結合了對關鍵相關人員的訪談、臨床和專利分析以及供應鏈場景測試。

本執行摘要中的洞見基於結構化的調查方法，該方法整合了第一手和第二手研究信息，以確保其穩健性和可操作性。一級資訊來源包括對設備開發商、臨床研究人員、採購經理和最終用戶的訪談，旨在收集關於可用性、報銷障礙和採購標準等方面的實際觀點。這些定性資訊與公開的臨床試驗註冊資料、監管指導文件、專利趨勢和同行評審文獻進行交叉比對，以確定技術成熟度、安全性考慮和證據缺口。

整合領導者必須採取的策略挑戰和風險緩解措施，以將外骨骼創新轉化為永續的商業性和臨床價值。

外骨骼領域正處於一個關鍵的轉折點，技術進步、證據標準的提升和變革性的經營模式在此交匯融合，釋放出更廣泛的實際價值。為了充分利用這項變革，相關人員需要協調對人體工學設計、臨床檢驗和強大製造能力的投資，同時探索將可衡量的結果與效益掛鉤的商業模式。那些能夠在創新、切實可行的服務交付和合規性之間取得平衡的公司，將最有利於從先導計畫過渡到全面企業發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外骨骼市場：依產品類型分類

  • 全身外骨骼
  • 下半身外骨骼
    • 非動力下半身
    • 下肢動力
  • 上半身外骨骼
    • 胸部支撐
    • 醫療援助
    • 肩部支撐

第9章：外骨骼市場：依材料類型分類

  • 複合材料
    • 碳纖維
    • 聚合物複合材料
  • 鋼和合金
    • 重型結構
    • 輕型框架

第10章 外骨骼市場：依應用領域分類

  • 無障礙支持
    • 行動支持
    • 物理治療
  • 衛生保健
    • 為老年人提供支持
    • 復健和治療
    • 手術支援

第11章 外骨骼市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 外骨骼市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 外骨骼市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國外骨骼市場

第15章：中國外骨市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ABLE Human Motion SL
  • B-Temia
  • Comau SpA
  • CYBERDYNE INC.
  • Ekso Bionics Holdings, Inc.
  • German Bionic Systems GmbH
  • GOGOA MOBILITY ROBOTS, SL
  • HeroWear, LLC
  • Hocoma AG
  • Hyundai Motor Group
  • Laevo BV
  • Lifeward, Inc.
  • Lockheed Martin Corporation.
  • MAWASHI SCIENCE & TECHNOLOGY
  • Myomo Inc.
  • Ottobock SE
  • Panasonic Holdings Corporation
  • RB3D
  • Rex Bionics Ltd.
  • Robert Bosch GmbH
  • Shanghai Fourier Intelligence Co. Ltd.
  • Wandercraft
Product Code: MRR-033F7A232459

The Exoskeleton Market was valued at USD 1.19 billion in 2025 and is projected to grow to USD 1.42 billion in 2026, with a CAGR of 19.98%, reaching USD 4.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.19 billion
Estimated Year [2026] USD 1.42 billion
Forecast Year [2032] USD 4.26 billion
CAGR (%) 19.98%

A concise and strategic orientation for executives to align technology, clinical validation, and supply chain choices driving practical exoskeleton adoption

The emergence of wearable robotics has shifted exoskeletons from niche research prototypes to increasingly viable tools across healthcare, industrial ergonomics, and accessibility applications. This executive summary synthesizes technological advances, regulatory developments, supply chain dynamics, and stakeholder incentives that are reshaping adoption trajectories. It highlights where clinical validation, user-centric design, and manufacturing scale intersect to create competitive advantage, and it frames the operational trade-offs executives must weigh when investing in product development, trials, or strategic partnerships.

As stakeholders evaluate the next wave of commercial deployments, emphasis has moved toward interoperability, user comfort, and demonstrable outcomes rather than novelty alone. Consequently, success now depends on aligning cross-functional capabilities-clinical evidence generation, human factors engineering, component sourcing, and service delivery-to ensure devices deliver measurable improvements in mobility, workplace safety, or rehabilitative outcomes. This summary aims to guide leadership teams in prioritizing interventions that accelerate adoption while mitigating technical, regulatory, and supply-side risks.

Several transformative shifts are converging to redefine the competitive and operational landscape for exoskeleton developers and adopters. Advances in lightweight materials, sensor fusion, low-latency control algorithms, and battery density are enabling devices that are more comfortable, reliable, and suited for prolonged daily use. Concurrently, an increased emphasis on human-centered design has prioritized comfort and ease of integration into existing workflows, bringing forward products that are evaluated on usable outcomes rather than purely technical specifications.

In parallel, the clinical evidence base has matured: longer-duration studies and broader functional endpoints are improving stakeholder confidence among clinicians, payers, and employers. This shift is encouraging new commercial models that combine device provision with outcome-based service contracts and rehabilitation-as-a-service structures. Finally, digital connectivity and remote monitoring capabilities are converting isolated devices into networked care and workplace safety platforms, enabling longitudinal performance tracking and proactive maintenance that reduce total cost of ownership and increase user trust.

Analysis of how evolving United States tariff measures in 2025 are reshaping sourcing, manufacturing footprint, and procurement risk management for exoskeleton stakeholders

Trade policy and tariff adjustments in 2025 have introduced renewed considerations for procurement strategies, supplier selection, and capital investment decisions across the exoskeleton ecosystem. Higher duties on some imported components, combined with ongoing logistics volatility and changing country-of-origin requirements, have increased the importance of resilient sourcing strategies and closer supplier partnerships. These dynamics have compelled manufacturers to reassess bill-of-materials composition, negotiate longer-term contracts with critical suppliers, and explore local or regional assembly to reduce exposure to tariff and transit risks.

As a result, procurement teams are placing greater emphasis on tariff classification accuracy, customs compliance, and alternative routing to mitigate cost pass-through. In addition to near-term transactional effects, tariff-driven uncertainty has accelerated conversations around regional manufacturing hubs and vertical integration for high-value, tariff-sensitive components such as actuators, battery modules, and composite structural elements. Consequently, companies are balancing the capital intensity of reshoring against the operational advantages of reduced lead times, improved quality control, and closer collaboration with design and testing teams.

Detailed segmentation insights showing how product architecture, material choices, and application focus create distinct commercial and technical pathways for exoskeletons

Segment-level dynamics reveal differentiated opportunity and risk profiles across product types, material choices, and application domains. Based on Product Type, market is studied across Full Body Exoskeletons, Lower Body Exoskeletons, and Upper Body Exoskeletons. The Lower Body Exoskeletons is further studied across Non-Powered Lower Body and Powered Lower Body. The Upper Body Exoskeletons is further studied across Chest Support, Medical Enhancements, and Shoulder Support. Full body systems increasingly target complex rehabilitative and industrial tasks requiring coordinated control across multiple joints, whereas lower body variants tend to focus on mobility assistance and workplace load redistribution. Within lower body offerings, non-powered solutions emphasize passive support and affordability while powered lower body systems prioritize active assistance and clinical-grade performance. Upper body devices span passive chest support to medically oriented shoulder and chest enhancement modules that address discrete functional deficits or workload distribution.

Based on Material Type, market is studied across Composites and Steel & Alloys. The Composites is further studied across Carbon Fibers and Polymeric Composites. The Steel & Alloys is further studied across Heavy-Duty Constructs and Lightweight Frames. Composite structures, particularly carbon fiber and advanced polymeric composites, provide strength-to-weight advantages that enhance wearer comfort and increase battery endurance, whereas steel and alloy frameworks remain attractive for heavy-duty industrial applications requiring robustness and cost efficiency. Innovations in hybrid material systems and modular architectures are enabling manufacturers to tailor stiffness, durability, and cost parameters to specific customer segments.

Based on Application, market is studied across Accessibility Aids and Healthcare. The Accessibility Aids is further studied across Mobility Assistance and Physical Therapy. The Healthcare is further studied across Elderly Assistance, Rehabilitation & Therapy, and Surgical Assistance. Accessibility-oriented devices emphasize ease of use, intuitiveness, and durable value propositions for independent users, while healthcare applications require rigorous clinical validation, integration into care pathways, and compatibility with reimbursement mechanisms. Rehabilitation and elderly assistance impose different usability and safety specifications than surgical assistive modules, prompting specialized control strategies and service models to support diverse clinical workflows.

Comparative regional perspectives revealing how regulatory frameworks, procurement practices, and manufacturing ecosystems influence exoskeleton adoption across global markets

Regional dynamics are shaping where innovation, commercialization, and adoption occur, with each geography presenting distinctive regulatory climates, healthcare priorities, and industrial end-use cases. Americas continue to combine strong private sector investment, healthcare provider networks with an appetite for pilot deployments, and defense and industrial use cases that prioritize ruggedness and scalable service models. The regulatory landscape in North America increasingly emphasizes empirical outcomes and interoperability, prompting suppliers to demonstrate longitudinal benefits and to integrate remote monitoring for payer and employer reassurance.

Europe, Middle East & Africa exhibits a heterogeneous set of drivers where robust public healthcare systems and stringent safety standards create both barriers to entry and clear pathways for devices that can demonstrate clinical effectiveness and cost efficiency. Fragmented reimbursement pathways encourage consortium-based adoption models and partnerships with compliance specialists. In contrast, market opportunities in some Middle Eastern and African markets are emerging through public procurement for rehabilitation and occupational safety programs. Asia-Pacific features rapid technology adoption in select urban centers, strong manufacturing ecosystems for components, and government-led initiatives to modernize eldercare and industrial productivity. Governments and private sector actors in the region are actively exploring localized production and public-private partnerships to accelerate trials and deployments.

Corporate strategic dynamics emphasizing platformization, evidence-driven product positioning, and service-oriented revenue models among leading exoskeleton stakeholders

Competitive positioning is increasingly defined by an organization's ability to combine compelling hardware, validated clinical outcomes, and scalable service delivery. Leading developers and manufacturers are adopting hybrid business models that combine device sales with outcome-linked services, maintenance programs, and data-driven subscription offerings. Strategic partnerships between technology specialists, clinical networks, and industrial distributors are common, enabling faster pilot programs and deeper integration into user workflows. Intellectual property portfolios around control algorithms, sensor fusion, and lightweight structures are critical assets that differentiate firms and can be leveraged in licensing or cross-licensing arrangements.

Investment patterns show sustained interest in firms that move beyond single-product propositions toward platform approaches that support modular upgrades and multi-application use. Mergers and acquisitions activity tends to favor targets with strong clinical evidence, established procurement channels in healthcare or industrial markets, and proprietary supply chain capabilities for high-cost components. Additionally, companies that prioritize post-sale services-training, remote monitoring, and outcome verification-are better positioned to capture long-term value and to build defensible recurring revenue streams.

Actionable strategic guidance for executives to accelerate adoption by focusing on usability, evidence generation, resilient supply chains, and outcome-based commercial models

Industry leaders should prioritize building integrated capabilities across product development, clinical validation, and supply chain resilience to capture near-term adoption windows. Investing in human factors and iterative usability testing will reduce abandonment risk and accelerate acceptance among clinicians and frontline workers. Simultaneously, organizations should invest in longitudinal clinical studies and real-world evidence generation to support procurement decisions by healthcare systems and large employers, thereby unlocking more sustainable commercialization pathways.

On the operational front, diversify supplier relationships for tariff-sensitive components and evaluate regional assembly to reduce lead-time risk while maintaining cost discipline. Form strategic partnerships with rehabilitation providers, industrial safety organizations, and insurance intermediaries to pilot outcome-linked reimbursement or employer-funded adoption programs. Finally, commercial teams should design service propositions that include training, remote monitoring, and performance verification, thereby aligning payment flows with realized outcomes and creating recurring revenue opportunities that underpin longer-term valuation growth.

Transparent and reproducible research methodology combining primary stakeholder interviews, clinical and patent analysis, and supply chain scenario testing to underpin findings

The insights in this executive summary draw on a structured research methodology that integrates primary and secondary evidence sources to ensure robustness and practical relevance. Primary inputs include interviews with device developers, clinical researchers, procurement leaders, and end users to capture on-the-ground perspectives about usability, reimbursement barriers, and procurement criteria. These qualitative inputs are triangulated with public clinical trial registries, regulatory guidance documents, patent landscapes, and peer-reviewed literature to map technology maturation, safety considerations, and evidence gaps.

Supplementing these sources, supply chain analyses examine component sourcing, tariff exposure, and lead-time variability to understand operational risks. Scenario analyses and sensitivity testing are used to explore how policy shifts, technology improvements, or capital allocation choices could alter strategic priorities. Throughout the methodology, emphasis is placed on transparency of assumptions, reproducibility of analyses, and the credibility of primary-source quotations to ensure the findings are actionable for corporate leadership and public-sector decision-makers.

Synthesis of strategic imperatives and risk mitigations that leaders must pursue to convert exoskeleton innovation into sustained commercial and clinical value

The exoskeleton sector stands at a pivotal inflection point where technological progress, improving evidence standards, and shifting commercial models are converging to unlock broader real-world value. To capitalize on this transition, stakeholders must coordinate investments in ergonomic design, clinical validation, and resilient manufacturing while exploring commercial structures that align payment with measurable outcomes. Those that balance innovation with pragmatic service delivery and regulatory compliance will be best positioned to transition from pilot projects to scaled operations.

While challenges remain-regulatory complexity, interoperability, and tariff-driven supply risks-there are clear pathways for executives to mitigate these barriers through targeted partnerships, regional manufacturing strategies, and a focus on evidence generation. The actionable insights provided here are intended to inform strategic planning and to catalyze initiatives that convert technical promise into durable commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Exoskeleton Market, by Product Type

  • 8.1. Full Body Exoskeletons
  • 8.2. Lower Body Exoskeletons
    • 8.2.1. Non-Powered Lower Body
    • 8.2.2. Powered Lower Body
  • 8.3. Upper Body Exoskeletons
    • 8.3.1. Chest Support
    • 8.3.2. Medical Enhancements
    • 8.3.3. Shoulder Support

9. Exoskeleton Market, by Material Type

  • 9.1. Composites
    • 9.1.1. Carbon Fibers
    • 9.1.2. Polymeric Composites
  • 9.2. Steel & Alloys
    • 9.2.1. Heavy-Duty Constructs
    • 9.2.2. Lightweight Frames

10. Exoskeleton Market, by Application

  • 10.1. Accessibility Aids
    • 10.1.1. Mobility Assistance
    • 10.1.2. Physical Therapy
  • 10.2. Healthcare
    • 10.2.1. Elderly Assistance
    • 10.2.2. Rehabilitation & Therapy
    • 10.2.3. Surgical Assistance

11. Exoskeleton Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Exoskeleton Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Exoskeleton Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Exoskeleton Market

15. China Exoskeleton Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. ABLE Human Motion S.L.
  • 16.6. B-Temia
  • 16.7. Comau S.p.A.
  • 16.8. CYBERDYNE INC.
  • 16.9. Ekso Bionics Holdings, Inc.
  • 16.10. German Bionic Systems GmbH
  • 16.11. GOGOA MOBILITY ROBOTS, SL
  • 16.12. HeroWear, LLC
  • 16.13. Hocoma AG
  • 16.14. Hyundai Motor Group
  • 16.15. Laevo BV
  • 16.16. Lifeward, Inc.
  • 16.17. Lockheed Martin Corporation.
  • 16.18. MAWASHI SCIENCE & TECHNOLOGY
  • 16.19. Myomo Inc.
  • 16.20. Ottobock SE
  • 16.21. Panasonic Holdings Corporation
  • 16.22. RB3D
  • 16.23. Rex Bionics Ltd.
  • 16.24. Robert Bosch GmbH
  • 16.25. Shanghai Fourier Intelligence Co. Ltd.
  • 16.26. Wandercraft

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXOSKELETON MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXOSKELETON MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXOSKELETON MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES EXOSKELETON MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA EXOSKELETON MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXOSKELETON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXOSKELETON MARKET SIZE, BY CHEST SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXOSKELETON MARKET SIZE, BY CHEST SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXOSKELETON MARKET SIZE, BY CHEST SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXOSKELETON MARKET SIZE, BY MEDICAL ENHANCEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXOSKELETON MARKET SIZE, BY MEDICAL ENHANCEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXOSKELETON MARKET SIZE, BY MEDICAL ENHANCEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXOSKELETON MARKET SIZE, BY SHOULDER SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXOSKELETON MARKET SIZE, BY SHOULDER SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXOSKELETON MARKET SIZE, BY SHOULDER SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXOSKELETON MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXOSKELETON MARKET SIZE, BY COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXOSKELETON MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXOSKELETON MARKET SIZE, BY CARBON FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXOSKELETON MARKET SIZE, BY CARBON FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXOSKELETON MARKET SIZE, BY CARBON FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXOSKELETON MARKET SIZE, BY POLYMERIC COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXOSKELETON MARKET SIZE, BY POLYMERIC COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXOSKELETON MARKET SIZE, BY POLYMERIC COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXOSKELETON MARKET SIZE, BY HEAVY-DUTY CONSTRUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXOSKELETON MARKET SIZE, BY HEAVY-DUTY CONSTRUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXOSKELETON MARKET SIZE, BY HEAVY-DUTY CONSTRUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT FRAMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT FRAMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT FRAMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXOSKELETON MARKET SIZE, BY MOBILITY ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXOSKELETON MARKET SIZE, BY MOBILITY ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXOSKELETON MARKET SIZE, BY MOBILITY ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EXOSKELETON MARKET SIZE, BY REHABILITATION & THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXOSKELETON MARKET SIZE, BY REHABILITATION & THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EXOSKELETON MARKET SIZE, BY REHABILITATION & THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS EXOSKELETON MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL EXOSKELETON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 166. GCC EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GCC EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 170. GCC EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 172. GCC EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 173. GCC EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. G7 EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 200. G7 EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 202. G7 EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 203. G7 EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 205. G7 EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 210. NATO EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 212. NATO EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 215. NATO EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES EXOSKELETON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA EXOSKELETON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)